Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 201, Issue 11, Pages 1617-1624Publisher
OXFORD UNIV PRESS INC
DOI: 10.1086/652403
Keywords
-
Categories
Funding
- Centers for Disease Control and Prevention
- Agency for Healthcare Research and Quality
- Arizona Department of Health Services
- Office of Statewide Health Planning and Development
- Florida Agency for Health Care Administration
- Georgia Hospital Association
- Hawaii Health Information Corporation
- Indiana Hospital Association
- Iowa Hospital Association
- Kentucky Cabinet for Health and Family Services
- Maine Health Data Organization
- Health Services Cost Review Commission
- Michigan Health & Hospital Association
- Minnesota Hospital Association
- Hospital Industry Data Institute
- Nevada Department of Health and Human Services
- New York State Department of Health
- South Carolina State Budget Control Board
- Washington State Department of Health
- West Virginia Health Care Authority
Ask authors/readers for more resources
Background. In 2006, RotaTeq (RV5) was recommended for routine vaccination of United States (US) infants. We compared hospitalization rates for acute gastroenteritis among US children aged <5 years during pre-RV5 rotavirus seasons from 2000 through 2006 with those during the post-RV5 2007 and 2008 seasons. Methods. Using 100% hospital discharge data from 18 states, accounting for 49% of the US population, we calculated acute gastroenteritis hospitalization rates for children aged <5 years by rotavirus season, 8 age groups (0-2, 3-5, 6-11, 12-17, 18-23, 24-35, 36-47, and 48-59 months), and state. Results. Compared with the median rate for the 2000-2006 rotavirus seasons (101.1 hospitalizations per 10,000 children), the rates for 2007 and 2008 (85.5 and 55.5 hospitalizations per 10,000 children) were 16% and 45% lower, respectively. Children aged 0-2 months had a 28% reduction, those aged 6-23 months had a reduction of 50%, and children aged 3-5 months and 24-59 months had reductions ranging between 42% and 45% during the 2008 rotavirus season, compared with the median rate for 2000-2006 rotavirus seasons. Conclusions. The introduction of the RV5 vaccine was associated with a dramatic reduction in hospitalizations for acute gastroenteritis among US children during the 2008 rotavirus season.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available